Judith Koenig

Dr. Judith Koenig

orcid

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2013 in American Journal of Veterinary Research
Verified
Journal Article
Closed access
KLKaitlyn A. Link
Kaitlyn A. Link
JKJudith Koenig
Judith Koenig
ASAndressa Silveira
Andressa Silveira
BPBrandon L. Plattner
Brandon L. Plattner
BLBrandon Lillie
Brandon Lillie
Objective—To compare the effect of extracorporeal shock wave therapy (ESWT) on expression of fibroblast growth factor-7 (FGF-7), transforming growth factor-β1 (TGF-β1), insulin-like growth factor-1 (IGF-1), platelet-derived growth factor-A (PDGF), and vascular endothelial growth factor-A (VEGF) in skin with surgically created skin wounds and intact skin in horses. Animals—14 healthy horses. Procedure—8 horses were treated with ESWT at 6 locations along the neck at 36, 24, 12, 6, 2, or 1 hour prior to collection of full-thickness biopsy specimens from each location; a control specimen was collected from a sham-treated location. In 6 horses, 5 full-thickness wounds were created in each forelimb. Wounds in 1 forelimb/horse received ESWT immediately after creation and subsequently on days 7, 14, and 21; wounds in the contralateral forelimb remained untreated. Biopsy specimens were collected from 1 wound on each forelimb on days 7, 14, 21, 28, and 35. Expression levels of FGF-7, TGF-β1, IGF-1, PDGF, and VEGF were assessed in tissue samples from the horses' necks and forelimbs. Results—In surgically created wounds, ESWT treatment was associated with reduced TGF-β1 expression, compared with expression in control wounds, during the entire study period. At 28 days following wound creation, IGF-1 expression was significantly increased for treated and untreated wounds, compared with findings on days 7, 14, 21, and 35. There was no significant effect of treatment on FGF-7, TGF-β1, IGF-1, PDGF, or VEGF expression in intact skin. Conclusions and Clinical Relevance—Intervention with ESWT to suppress TGF-β1 may decrease granulation tissue production, resulting in improved wound healing on the distal portion of horses' limbs.

1 September 2020 in Journal of Equine Veterinary Science
Verified
Journal Article
Closed access
JKJudith Koenig
Judith Koenig
AWAmy Westlund
Amy Westlund
SNStephanie Nykamp
Stephanie Nykamp
DKDaniel G. Kenney
Daniel G. Kenney
LMLisa Melville
Lisa Melville
DODieter Oberbichler
Dieter Oberbichler

4 December 2020 in Frontiers in Veterinary Science
Verified
Journal Article
Open access
PDF file
RSRamés Salcedo-Jiménez
Ramés Salcedo-Jiménez
JKJudith Koenig
Judith Koenig
OLOlivia J. Lee
Olivia J. Lee
TGThomas W. G. Gibson
Thomas W. G. Gibson
PMPavneesh Madan
Pavneesh Madan
TKThomas G. Koch
Thomas G. Koch
Extracorporeal shock wave therapy (ESWT) has been shown to induce different biological effects on a variety of cells, including regulation and stimulation of their function and metabolism. ESWT can promote different biological responses such as proliferation, migration, and regenerations of cells. Recent studies have shown that mesenchymal stromal cells (MSCs) secrete factors that enhance the regeneration of tissues, stimulate proliferation and differentiation of cells, and decrease inflammatory and immune reactions. Clinically, the combination of these two therapies has been used as a treatment for tendon and ligament lesions in horses; however, there is no scientific evidence supporting this combination of therapies in vivo. Therefore, the objectives of the study were to evaluate the effects of ESWT on equine umbilical cord blood mesenchymal stromal cells (CB-MSCs) proliferative, metabolic, migrative, differentiation, and immunomodulatory properties in vitro. Three equine CB-MSC cultures from independent donors were treated using an electrohydraulic shock wave generator attached to a water bath. All experiments were performed as triplicates. Proliferation, viability, migration and immunomodulatory properties of the cells were evaluated. Equine CB-MSCs were induced to evaluate their trilineage differentiation potential. ESWT treated cells had increased metabolic activity, showed positive adipogenic, osteogenic, and chondrogenic differentiation, and showed higher potential for differentiation toward the adipogenic and osteogenic cell fates. ESWT treated cells showed similar immunomodulatory properties to none-ESWT treated cells. Equine CB-MSCs are responsive to ESWT treatment and showed increased metabolic, adipogenic and osteogenic activity, but unaltered immunosuppressive properties. In vivo studies are warranted to determine if synergistic effects occur in the treatment of musculoskeletal injuries if ESWT and equine CB-MSC therapies are combined.

1 April 2007 in Journal of the American Veterinary Medical Association
Verified
Journal Article
Open access
LRLuis M. Rubio-Martínez
Luis M. Rubio-Martínez
JKJudith Koenig
Judith Koenig
KHKrista B. Halling
Krista B. Halling
KWKatharine Wilkins
Katharine Wilkins
KSKara Schulz
Kara Schulz
Case Description—A 3-year-old male alpaca was evaluated because of non–weight-bearing lameness (grade 5/5) in the left hind limb. Clinical Findings—Clinical and radiographic examination revealed a closed, comminuted, nonarticular, displaced diaphyseal fracture of the left third and fourth metatarsal bones. Treatment and Outcome—Initial attempts at treatment via reduction of the fracture under traction and subsequent application of a cast were unsuccessful, and more stable fracture fixation was pursued. The alpaca underwent closed reduction of the fracture, which was stabilized by the application of a 3-ring circular external skeletal fixator (CESF). Improved weight bearing on the affected limb was evident soon after surgery and gradually increased; full weight bearing was evident by the seventh day after discharge from the hospital (day 20 after application of the CESF). Lameness was hardly noticeable during walking at that time. After 3 months, complete fracture healing was evident and the CESF was removed; mild outward rotation of the distal fragment and metatarsophalangeal joint was present. A Robert Jones bandage was applied to the limb, and the alpaca was kept in a stall for another 4 weeks. Eleven months after CESF application, the owners and referring veterinarian reported that the alpaca was healthy, not lame, and serving as a stallion without apparent impediment. Clinical Relevance—Although mostly restricted to small animals, application of a CESF can be a viable alternative for management of long bone fractures in South American camelids.

13 May 2025 in Equine Veterinary Journal
Verified
Journal Article
Open access
RLRodrigo Munevar Luque
Rodrigo Munevar Luque
BHBri Henderson
Bri Henderson
TMTerence Connor McCorkell
Terence Connor McCorkell
AAAmir Hamed Alizadeh
Amir Hamed Alizadeh
KRKeith A. Russell
Keith A. Russell
JKJudith Koenig
Judith Koenig
Background: Mesenchymal stromal cells (MSCs) are widely used to treat osteoarthritis (OA). Optimising dose, timing, and safety while comparing efficacy with standard therapies like hyaluronic acid (HA) is essential for their standardisation. Objectives: To assess the safety and efficacy of equine umbilical cord‐derived (eCB) MSCs in client‐owned horses with fetlock or carpus OA. Study Design: Prospective single‐blinded randomised clinical study. Methods: Horses diagnosed with fetlock or carpus OA via intra‐articular (IA) anaesthesia were randomly assigned to receive either 10 or 20 million eCB‐MSCs in HA or 3 mL of HA alone (control). Subjective lameness examinations were performed at baseline, 3 weeks, and 6 weeks post‐treatment. Adverse reactions were evaluated 24–72 h post‐injection. Follow‐up surveys were sent to owners at 18 weeks. Results: Twenty‐seven client‐owned horses were enrolled. No significant adverse reactions occurred. Lameness outcomes did not differ significantly between treatment groups at 3 or 6 weeks ( p > 0.05), though all groups showed improvement over time ( p < 0.05). Median lameness change at 6 weeks was −1.5 (0.5) grades for HA, −2.0 (1.0) for 10‐MSC + HA, and −2.0 (1.0) for 20‐MSC + HA. Although return‐to‐work rates were not significantly different ( p > 0.05), both MSC + HA groups had higher return rates to the same or higher work levels than HA‐only (8 out of 9, 7 out of 9, and 5 out of 9, respectively). Main Limitations: Small sample size. Conclusions: The study aimed to assess MSC treatment safety and efficacy. Higher return‐to‐exercise rates were expected in the MSC groups at 18 weeks, but unexpectedly high rates in the HA group may have led to underpowering. A post hoc calculation suggests 30 horses per group would be needed to detect significant differences.

1 October 2009 in American Journal of Veterinary Research
Verified
Journal Article
Closed access
JKJudith Koenig
Judith Koenig
JHJames Hart
James Hart
DHDavid M. Harris
David M. Harris
AMAntonio Manuel Cruz Madorran
Antonio Manuel Cruz Madorran
DBDorothee Bienzle
Dorothee Bienzle
Objective—To evaluate the performance of a chemiluminescent endotoxin activity assay in horses with colic and healthy horses. Animals—20 horses with colic and systemic inflammatory response syndrome (SIRS group), 8 horses with colic with no SIRS (NSIRS group), and 20 healthy horses. Procedures—Venous blood was collected into EDTA blood collection tubes after completion of a physical examination, and a chemiluminescent endotoxin activity assay was performed within 60 minutes of collection. Medical or surgical interventions and outcome were recorded for each horse. Results—Mean ± SE endotoxin activity was 0.16 ± 0.05 for healthy horses, 0.18 ± 0.07 for the NSIRS group, and 0.53 ± 0.05 for the SIRS group and was significantly different among the groups. Mean endotoxin activity was significantly higher in the SIRS group than in the NSIRS group and the healthy group. No significant difference between the healthy and NSIRS groups was present. The higher the measured endotoxin activity, the more likely it was for horses to be euthanized. Conclusions and Clinical Relevance—The chemiluminescent endotoxin assay was easy to use, required a short time to perform, could be completed at the patient's side, and with some modifications, may be a useful component in the clinical assessment and prognostication of horses with colic.